Skip to Main Content

Paper Details

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
J Neuroinflammation
40
2021
Author NameAffiliation
David LeppertNeurologic Clinic and Policlinic, Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Hanna ZimmermannNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Hanna ZimmermannExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Alexander U BrandtUniversity of California irvine
Alexander U BrandtExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Alexander U BrandtNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Friedemann PaulCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Friedemann PaulNeuroCure Clinical Research Center, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Friedemann PaulExperimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
  • 1 - 9

Datasets